Poor treatment outcomes of keratinocytic carcinoma and barriers to Mohs micrographic surgery highlights the need to address access and coverage among Medicaid beneficiaries

J Am Acad Dermatol. 2023 Jul;89(1):168-169. doi: 10.1016/j.jaad.2023.02.037. Epub 2023 Mar 1.

Authors

Eric J Beltrami¹, Vijay Kodumudi¹, Christian Gronbeck², Hao Feng³

Affiliations

¹ University of Connecticut School of Medicine, Farmington, Connecticut.
² Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.
³ Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut. Electronic address: haofeng625@gmail.com.

PMID: 36863579
DOI: 10.1016/j.jaad.2023.02.037

No abstract available

Keywords: Medicaid; Medicaid acceptance; Mohs micrographic surgery; Mohs surgeons; access; disparity; keratinocytic carcinoma.

Publication types

Comment

MeSH terms

Carcinoma* / surgery
Carcinoma, Basal Cell* / pathology
Humans
Medicaid
Mohs Surgery
Skin Neoplasms* / pathology
Skin Neoplasms* / surgery
Treatment Outcome